Educational only — not medical advice. If you’re in crisis or thinking about suicide: call or text 988 (U.S.) or your local emergency number. Support resources. Under construction and review—see the updates log.
Max 4 meds. Sources include DailyMed labels; verify against official labeling. On small screens the table defaults to a compact view—use “Show all columns” to view everything (scroll horizontally).
Compare 3/4 selected
| Medication | Dosing highlights | Risk flags | LAI options |
|---|---|---|---|
Confirm oral tolerability and response before depot conversion when feasible. Conversion is individualized; labeling commonly describes an initial monthly dose roughly 10–15× the total daily oral dose. |
| q4wk | |
Administration is intramuscular every 2 weeks. Dose selection is individualized to response and tolerability within labeled ranges. |
| q2wk | |
paliperidone palmitateLong-acting injectable antipsychoticBrands: INVEGA SUSTENNA, INVEGA TRINZA, INVEGA HAFYERA View labelExact | PP1M initiation uses a labeled loading sequence (deltoid injections on day 1 and day 8) followed by monthly maintenance. Oral overlap is not typically required after the loading sequence. |
| Monthly / q3mo / q6mo |
2 more columns available — use “Show all columns” above.5 more columns available — use “Show all columns” above.6 more columns available — use “Show all columns” above.